Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iovance Biotherapeutics (IOVA) Other Non Operating Income: 2010-2012

Historic Other Non Operating Income for Iovance Biotherapeutics (IOVA) over the last 2 years, with Sep 2012 value amounting to $1.6 million.

  • Iovance Biotherapeutics' Other Non Operating Income fell 54.99% to $1.6 million in Q3 2012 from the same period last year, while for Sep 2012 it was -$6.8 million, marking a year-over-year decrease of 328.00%. This contributed to the annual value of $200,000 for FY2015, which is 3233.33% up from last year.
  • Per Iovance Biotherapeutics' latest filing, its Other Non Operating Income stood at $1.6 million for Q3 2012, which was down 17.22% from $1.9 million recorded in Q2 2012.
  • Over the past 5 years, Iovance Biotherapeutics' Other Non Operating Income peaked at $3.5 million during Q3 2011, and registered a low of -$7.7 million during Q4 2011.
  • Over the past 3 years, Iovance Biotherapeutics' median Other Non Operating Income value was -$245,845 (recorded in 2010), while the average stood at -$486,792.
  • The largest annual percentage gain for Iovance Biotherapeutics' Other Non Operating Income in the last 5 years was 748.59% (2011), contrasted with its biggest fall of 3,039.06% (2011).
  • Over the past 3 years, Iovance Biotherapeutics' Other Non Operating Income (Quarterly) stood at -$245,845 in 2010, then crashed by 3,039.06% to -$7.7 million in 2011, then crashed by 54.99% to $1.6 million in 2012.
  • Its Other Non Operating Income was $1.6 million in Q3 2012, compared to $1.9 million in Q2 2012 and -$2.6 million in Q1 2012.